Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.945
+0.085 (4.57%)
Mar 4, 2026, 11:47 AM EST - Market open
Ocugen Market Cap
Ocugen has a market cap or net worth of $637.74 million as of March 4, 2026. Its market cap has increased by 204.35% in one year.
Market Cap
637.74M
Enterprise Value
639.78M
1-Year Change
204.35%
Ranking
Category
Stock Price
$1.95
Market Cap Chart
Since September 30, 2019, Ocugen's market cap has increased from $32.75M to $637.74M, an increase of 1,847.34%. That is a compound annual growth rate of 58.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 609.87M | 44.65% |
| Dec 31, 2025 | 421.63M | 79.79% |
| Dec 31, 2024 | 234.51M | 59.00% |
| Dec 29, 2023 | 147.49M | -48.17% |
| Dec 30, 2022 | 284.55M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jade Biosciences | 639.92M |
| Alto Neuroscience | 624.74M |
| Vor Biopharma | 620.72M |
| Zura Bio | 615.74M |
| YD Bio | 613.89M |
| LB Pharmaceuticals | 604.90M |
| Alpha Tau Medical | 602.82M |
| Rigel Pharmaceuticals | 599.36M |